Market Trends of Veterinary Antimicrobial Susceptibility Testing Industry
The Automated Testing Systems Segment is Expected to Dominate the Veterinary Antimicrobial Susceptibility Testing Market During the Forecast Period
Automated testing systems play a pivotal role in the veterinary antimicrobial susceptibility testing market, offering efficient and standardized methods to assess the susceptibility of microbial pathogens to antimicrobial agents. These systems streamline the testing process, providing accurate and timely results that are crucial for effective treatment decisions in veterinary medicine.
Automated testing systems enable high-throughput screening of multiple samples simultaneously, significantly reducing testing time compared to manual methods. This efficiency is crucial in veterinary settings with a high caseload. For instance, in June 2023, the PA-100 AST System, developed by Sysmex Europe SE based in Norderstedt, Germany, is a state-of-the-art automated urine analyzer that accelerates antimicrobial susceptibility testing (AST) directly at the point of care. It utilizes a unique combination of phase contrast microscopy and nanofluidics to produce antibiograms onsite. This advanced technology, based on nanofluidics, guarantees exceptional diagnostic accuracy. With its user-friendly interface and efficient operation, the PA-100 AST System can detect bacterial growth and conduct AST within an hour, yielding results that adhere to EUCAST standards.
Hence, ongoing technological advancements and product approvals for automated testing systems are further projected to propel the growth of the veterinary antimicrobial susceptibility testing market.
North America is Expected to Dominate the Veterinary Antimicrobial Susceptibility Testing Market
Antibiotics are prevalent in animal husbandry to promote growth and prevent infections in livestock and poultry. However, this practice leads to the emergence of antibiotic-resistant bacteria, which can be transmitted to humans through the food chain. Consequently, it poses a risk to food security, compromising both the availability and safety of food.
To effectively tackle antibiotic resistance, it is crucial to foster cooperation among various stakeholders, such as government bodies, businesses, educational institutions, and advocates for animal health. Furthermore, key product launches, the high concentration of market players, and the manufacturer's presence in the United States are some of the factors driving the growth of the country's veterinary antimicrobial susceptibility testing market.
For instance, in June 2023, Avails Medical, a manufacturer of rapid, automated, and fully electrical antibiotic susceptibility testing (AST) solutions, announced the submission of its eQUANTTM system for US FDA 510(k) clearance. The system can provide standardized inoculum directly from a positive blood culture, designed to be used with traditional automated AST systems and disk diffusion, accelerating routine AST turnaround times by up to one day. Therefore, owing to these benefits being incorporated into products, the market studied is anticipated to grow in North America.
